Drug resistance factors in acute myeloid leukemia: a comparative analysis
Open Access
- 6 January 2000
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 14 (1), 68-76
- https://doi.org/10.1038/sj.leu.2401634
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Expression of the Lung Resistance Protein Predicts Poor Outcome in De Novo Acute Myeloid LeukemiaBlood, 1998
- Multidrug resistance in leukemiaCurrent Opinion in Hematology, 1998
- The proto-oncogene Bcl-2 and its role in regulating apoptosisNature Medicine, 1997
- P-Glycoprotein Expression in De Novo Acute Myeloid LeukemiaLeukemia & Lymphoma, 1997
- Simultaneous Expression of P-Glycoprotein and BCL-2 in Acute Myeloid Leukemia Blast CellsLeukemia & Lymphoma, 1997
- Multidrug Resistance in Leukemias and its ReversalLeukemia & Lymphoma, 1996
- P‐glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survivalBritish Journal of Haematology, 1994
- High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapyBlood, 1993
- Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]Blood, 1992
- Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivityBlood, 1991